Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00518141
Other study ID # S-06085 (REK)
Secondary ID
Status Completed
Phase N/A
First received August 17, 2007
Last updated July 20, 2011
Start date March 2006
Est. completion date May 2009

Study information

Verified date July 2011
Source Sykehuset Telemark
Contact n/a
Is FDA regulated No
Health authority Norway:National Committee for Medical and Health Research Ethics
Study type Interventional

Clinical Trial Summary

This study aims to determine the possible effects of Acetyl Salicylic Acid (ASA) and Terbutalin on ART treatment.


Description:

This study aims to determine the possible effects of ASA and Terbutalin on ART treatment.


Recruitment information / eligibility

Status Completed
Enrollment 300
Est. completion date May 2009
Est. primary completion date May 2009
Accepts healthy volunteers No
Gender Female
Age group 18 Years to 39 Years
Eligibility Inclusion Criteria:

- Infertile women below 39 years of age

Exclusion Criteria:

- Women who may react allergically to the drugs administered

- Women with hyperthyroid or IDDM

- Women who do not want to participate in the study

- Women who are unable to give informed, written consent.

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms

  • Reproductive Techniques, Assisted

Intervention

Drug:
Acetyl Salicylic Acid and Terbutalin
ASA 75 mg, Terbutalin 5mg

Locations

Country Name City State
Norway STHF, Kvinneklinikken, Fertilitetsklinikken Sor Porsgrunn Telemark

Sponsors (1)

Lead Sponsor Collaborator
Sykehuset Telemark

Country where clinical trial is conducted

Norway, 

Outcome

Type Measure Description Time frame Safety issue
Primary Pregnancy 7 weeks No
See also
  Status Clinical Trial Phase
Recruiting NCT05442125 - First Live Birth Rate With eSET After Preimplantation Methylome Screening (PIMS) Versus Conventional In-vitro Fertilization N/A
Withdrawn NCT00767611 - Molecular Markers of Human Sperm Function N/A
Completed NCT04549649 - The Effect of Dual Trigger for Final Oocyte Maturation on IVF/ICSI Outcomes in Patients With Suboptimal Ovarian Response N/A
Completed NCT02457481 - An Alternative Culture Medium to Better Support Preimplantation Embryo Development in Vitro N/A
Completed NCT02567552 - Clinical Trial Comparing Endometrial Transformation With Subcutaneous Progesterone Versus Intramuscular Progesterone Phase 4
Terminated NCT01071200 - Study to Evaluate if the Addition of r-hLH (Luveris®) to FSH From Day 8 of Ovarian Stimulation is Able to Decrease Total FSH Dose and to Improve Cycle Outcome in Infertile Women Undergoing ART, Who Required High FSH Dose in a Previous Cycle Phase 3
Recruiting NCT02516462 - In Vitro Maturation of Human Eggs N/A
Recruiting NCT05473039 - Effect of a Multivitamin Supplement With Probiotic (Seidivid Ferty4®) on Oocyte Retrieval and Quality N/A
Recruiting NCT04124913 - Oral Dydrogesterone vs. Micronized Vaginal Progesterone for Luteal Phase Support in Frozen-thawed Embryo Transfer Cycles Phase 4
Completed NCT02381821 - Endometrial Volume and Sub-endometrial Vascularity as Predictors of In-vitro Fertilization Success N/A
Recruiting NCT02625519 - Efficacy of Urinary Vs Recombinant FSH in Oocyte Donors Based on Receptor N680S FSH Gene Polymorphism (Genodon Trial) Phase 4
Active, not recruiting NCT02625532 - Early Follicular Phase vs Lutheal Phase Ovarian Stimulation in Bologna Criteria IVF/ICSI Cycles (LUTEAL Trial) N/A
Completed NCT04458454 - "Study of the Effects of Serum and Follicular Fluid Relaxin Levels on Ovarian Function in IVF Cycles"
Active, not recruiting NCT03901170 - Does Letrozole Improve Pregnancy Outcome in Fresh Embryo Transfer IVF/ICSI Cycle? Phase 4